Effect of Qizhu prescription on a mouse model of non-alcoholic fatty liver disease incluced by high-fat, high-fructose, and high-cholesterol diet and its mechanism
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 11
Abstract
[Objective] To investigate the therapeutic effect and mechanism of action of Qizhu prescription in mice with non-alcoholic fatty liver disease (NAFLD). [Methods] A total of 60 male C57BL/6J mice were randomly divided into normal group, model group, low-dose Qizhu prescription group (4.75 g/kg), middle-dose Qizhu prescription group (9.50 g/kg), high-dose Qizhu prescription group (19.00 g/kg), Yishanfu group (228 mg/kg), with 10 mice in each group. After 16 weeks of modeling with a high-fat high-cholesterol diet and 20% fructose water, each group was given the corresponding drug once a day for 8 weeks. The serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL) were measured; ELISA was used to measure the serum levels of free fatty acid (FFA), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), superoxide dismutase (SOD), and malondialdehyde (MDA); HE staining and oil red O staining were used to the pathological changes of liver tissue; Western blot was used to measure the protein expression levels of LC3BⅡ/Ⅰ, p62/SQSTM1, Beclin-1, and Drp1, and real-time PCR was used to measure the mRNA expression levels of Drp1, Beclin-1, and p62/SQSTM1. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t-test was used for further comparison between two groups. [Results] Compared with the normal group, the model groups had significant increases in the serum levels of TG, TC, ALT, AST, LDL, FFA, TNF-α, IL-1β, and MDA and a significant reduction in the serum level of SOD (P<0.05). HE staining showed that the mice in the model group had hepatocyte steatosis and a large number of fat vacuoles in liver tissue, and oil red O staining showed that the mice in the model group had a large number of red lipid droplets of varying sizes in hepatocytes, with a significant increase in the percentage of oil red O staining area compared with the normal group (P<0.05). Real-time PCR showed that compared with the normal group, the model group had significant increases in the mRNA expression levels of Drp1 and Beclin-1 and a significant reduction in the mRNA expression level of p62/SQSTM1 in liver tissue (all P<0.05), and Western blot showed that compared with the normal group, the model group had significant increases in the protein expression levels of Drp1, Beclin-1, and LC3BⅡ/Ⅰ and a significant reduction in the protein expression level of p62/SQSTM1 in liver tissue (all P<0.05). Compared with the model group, some Qizhu prescription groups and the Yishanfu group had significant reductions in the serum levels of TG, TC, ALT, AST, LDL, FFA, TNF-α, IL-1β, and MDA and a significant increase in the serum level of SOD (all P<0.05). Compared with the model group, each administration group had a significant improvement in steatosis of liver tissue, a significant reduction in the percentage of oil red O staining area, significant reductions in the mRNA expression levels of Drp1 and Beclin-1, and a significant increase in the mRNA expression level of p62/SQSTM1 (all P<0.05); there were significant reductions in the protein expression levels of Drp1, Beclin-1, and LC3BⅡ/Ⅰ, while some administration groups had a significant increase in the protein expression level of p62/SQSTM1 (all P<0.05), with a significantly better effect in the middle- and high-dose Qizhu prescription groups (all P<0.01). [Conclusion] Qizhu prescription improves lipid metabolism and inflammation in mice with NAFLD possibly by regulating hepatocyte mitophagy.
Authors and Affiliations
Jiahao CHEN, Zhenhua ZHOU
Risk factors for biliary stricture and prognosis after orthotopic liver transplantation
[Objective] To investigate the risk factors for biliary stricture within two years after orthotopic liver transplantation, and analyze the survival. [Methods] A retrospective analysis was performed for the data of 495 p...
Expression of CXCL10 and CXCL12 in gallbladder carcinoma and their mechanism of action in tumor invasion
[Objective] To investigate the expression levels of CXCL10 and CXCL12 in gallbladder carcinoma and their mechanism of action in tumor invasion. [Methods] Tumor tissue samples and adjacent tissue samples were collected fr...
Experience in eliminating the mother-to-child transmission of hepatitis B virus in China
Reducing the mother-to-child transmission of hepatitis B virus (HBV) is crucial for achieving HBV elimination. Launched in July 2015 at the Great Hall of the People in Beijing, China, the “Zero Hepatitis B Mother-to-...
Value of liver biopsy in the diagnosis and clinical trial of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) constitutes a series of histological lesions characterized by varying degrees of hepatocyte damage, fat accumulation, inflammation, and fibrosis. Currently, liver biopsy is...
New advances in antiviral therapy during pregnancy to block mother-to-child transmission of hepatitis B virus
Mother-to-child transmission of hepatitis B virus (HBV) is one of the primary causes of the high disease burden of chronic hepatitis B in China, and blocking this route of transmission has an important strategic signi...